Bright Minds Biosciences (DRUG) Short Interest Ratio & Short Volume $36.78 +0.18 (+0.49%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Bright Minds Biosciences Short Interest DataBright Minds Biosciences (DRUG) has a short interest of 176,700 shares, representing 3.50% of the float (the number of shares available for trading by the public). This marks a -20.12% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 66,847 shares to cover all short positions.Current Short Interest176,700 sharesPrevious Short Interest221,200 sharesChange Vs. Previous Month-20.12%Dollar Volume Sold Short$6.36 millionShort Interest Ratio0.1 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares4,430,000 sharesFloat Size5,050,000 sharesShort Percent of Float3.50%Today's Trading Volume82,339 sharesAverage Trading Volume66,847 sharesToday's Volume Vs. Average123% Short Selling Bright Minds Biosciences? Sign up to receive the latest short interest report for Bright Minds Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDRUG Short Interest Over TimeDRUG Days to Cover Over TimeDRUG Percentage of Float Shorted Over Time Bright Minds Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/2024176,700 shares $6.36 million -20.1%3.5%0.1 $36.02 12/15/2024221,200 shares $9.07 million -0.1%4.4%0.1 $41.00 11/30/2024221,400 shares $9.74 million -16.4%4.4%0.1 $44.00 11/15/2024264,800 shares $10.49 million -17.9%5.2%0.1 $39.61 10/31/2024322,600 shares $15.10 million -72.4%11.7%0.1 $46.80 10/15/20241,170,000 shares $45.03 million +1,274.9%38.2%0.4 $38.49 9/30/202485,100 shares $99,567.00 -19.6%3.0%0.8 $1.17 9/15/2024105,900 shares $135,022.50 -41.7%3.7%1 $1.28 8/31/2024181,500 shares $192,390.00 +149.7%6.3%1.8 $1.06 8/15/202472,700 shares $74,881.00 +0.6%2.5%0.8 $1.03 Get the Latest News and Ratings for DRUG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter. 7/31/202472,300 shares $83,868.00 +3.6%2.5%3.4 $1.16 7/15/202469,800 shares $71,196.00 -2.0%2.4%3 $1.02 6/30/202471,200 shares $77,223.52 -0.4%2.5%6 $1.08 6/15/202471,500 shares $75,075.00 -13.5%2.5%4.5 $1.05 5/31/202482,700 shares $100,067.00 +17.5%2.9%4.4 $1.21 5/15/202470,400 shares $76,384.00 No Change2.5%3.6 $1.09 4/30/202470,400 shares $70,400.00 -7.0%2.6%3.3 $1.00 4/15/202475,700 shares $93,111.00 +7.2%2.8%3.1 $1.23 3/31/202470,600 shares $84,712.94 -3.6%2.6%2.5 $1.20 3/15/202473,200 shares $95,160.00 +3.1%2.7%2.2 $1.30 2/29/202471,000 shares $127,800.00 +0.3%2.6%2 $1.80 2/15/202470,800 shares $138,760.92 -0.4%2.5%1.9 $1.96 1/31/202471,100 shares $151,443.00 -9.1%2.9%2 $2.13 1/15/202478,200 shares $151,012.02 +7.6%3.2%2.6 $1.93 12/31/202372,700 shares $103,961.00 -5.6%3.0%2.4 $1.43 12/15/202377,000 shares $115,500.00 -9.4%3.0%3.3 $1.50 11/30/202385,000 shares $113,900.00 +21.6%3.3%3.6 $1.34 11/15/202369,900 shares $88,773.00 -1.4%2.7%2.3 $1.27 10/31/202370,900 shares $95,715.00 -1.3%2.7%1.1 $1.35 10/15/202371,800 shares $112,008.00 -1.0%2.8%0.1 $1.56 9/30/202372,500 shares $116,000.00 -1.0%2.8%0.1 $1.60 9/15/202373,200 shares $114,924.00 -12.8%2.8%0.1 $1.57 8/31/202383,900 shares $180,385.00 -50.7%3.2%0.1 $2.15 8/15/2023170,200 shares $451,030.00 +49.3%6.6%0.3 $2.65 7/31/2023114,000 shares $474,240.00 +16.9%4.4%0.2 $4.16 7/15/202397,500 shares $358,800.00 -80.7%3.8%0.9 $3.68 6/30/2023505,400 shares $1.44 million -7.5%3.8%0.7 $2.85 6/15/2023546,300 shares $319,694.76 -19.8%4.1%0.8 $0.59 5/31/2023680,900 shares $427,060.48 +15.9%4.8%1 $0.63 5/15/2023587,600 shares $317,304.00 -13.0%4.1%0.9 $0.54Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> 4/30/2023675,000 shares $424,372.50 +38.2%4.7%1 $0.63 4/15/2023488,600 shares $200,277.14 +2.2%3.4%0.7 $0.41 3/31/2023478,100 shares $210,411.81 -0.1%3.4%3.7 $0.44 3/15/2023478,500 shares $229,680.00 +0.8%3.4%2.8 $0.48 2/28/2023474,800 shares $273,603.50 -22.4%3.3%2.5 $0.58 2/15/2023612,100 shares $448,669.30 +4.3%4.4%2.8 $0.73 1/31/2023586,900 shares $422,157.17 +11.6%4.2%2.2 $0.72 1/15/2023525,700 shares $415,303.00 -21.8%3.8%1.9 $0.79 12/30/2022672,200 shares $497,428.00 -17.9%4.9%1.1 $0.74 12/15/2022818,500 shares $746,881.25 -0.8%8.3%1.2 $0.91 11/30/2022824,900 shares $899,141.00 -11.6%11.0%0.6 $1.09 11/15/2022932,900 shares $918,906.50 +23.0%12.5%0.1 $0.99 10/31/2022758,600 shares $751,014.00 +58.5%10.1%0.1 $0.99 10/15/2022478,500 shares $435,482.85 +34.6%6.4%0 $0.91 9/30/2022355,600 shares $437,388.00 -24.6%4.9%0 $1.23 9/15/2022471,600 shares $603,648.00 -58.6%6.5%0 $1.28 8/31/20221,140,000 shares $2.19 million +1,809.6%16.3%0.1 $1.92 8/15/202259,700 shares $59,538.81 +64.9%0.9%0 $1.00 7/31/202236,200 shares $36,022.62 +10.0%0.5%0.6 $1.00 7/15/202232,900 shares $28,043.93 +56.7%0.5%0.6 $0.85 6/30/202221,000 shares $16,793.70 -56.3%0.3%0.4 $0.80 6/15/202248,100 shares $44,405.92 +2.3%0.7%0.6 $0.92 5/31/202247,000 shares $51,700.00 +144.8%0.7%0.5 $1.10 5/15/202219,200 shares $18,721.92 -28.9%0.3%0.2 $0.98 4/30/202227,000 shares $25,245.00 -26.0%0.4%0.3 $0.94 4/15/202236,500 shares $46,997.40 -21.3%0.6%0.5 $1.29 3/31/202246,400 shares $70,393.44 +29.3%0.7%0.8 $1.52 3/15/202235,900 shares $55,645.00 -29.1%0.6%0.9 $1.55 2/28/202250,600 shares $105,754.00 +13.7%0.8%3.6 $2.09 2/15/202244,500 shares $107,690.00 -11.9%0.7%2.2 $2.42 1/31/202250,500 shares $122,715.00 +6.3%0.7%0.3 $2.43 1/15/202247,500 shares $135,850.00 +43.5%0.7%0.3 $2.86 12/31/202133,100 shares $104,927.00 No Change0.5%0.2 $3.17 DRUG Short Interest - Frequently Asked Questions What is Bright Minds Biosciences' current short interest? Short interest is the volume of Bright Minds Biosciences shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 176,700 shares of DRUG short. 3.50% of Bright Minds Biosciences' shares are currently sold short. Learn More on Bright Minds Biosciences' current short interest. What is a good short interest percentage for Bright Minds Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.50% of Bright Minds Biosciences' floating shares are currently sold short. Is Bright Minds Biosciences' short interest increasing or decreasing? Bright Minds Biosciences saw a decrease in short interest in December. As of December 31st, there was short interest totaling 176,700 shares, a decrease of 20.1% from the previous total of 221,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bright Minds Biosciences' float size? Bright Minds Biosciences currently has issued a total of 4,430,000 shares. Some of Bright Minds Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bright Minds Biosciences currently has a public float of 5,050,000 shares. How does Bright Minds Biosciences' short interest compare to its competitors? 3.50% of Bright Minds Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bright Minds Biosciences: Immunome, Inc. (19.24%), Evolus, Inc. (8.53%), Autolus Therapeutics plc (3.24%), Erasca, Inc. (20.06%), ORIC Pharmaceuticals, Inc. (16.21%), Kura Oncology, Inc. (16.00%), Tectonic Therapeutic (7.34%), CARGO Therapeutics, Inc. (18.87%), Humacyte, Inc. (28.38%), Pharvaris (0.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Bright Minds Biosciences stock? Short selling DRUG is an investing strategy that aims to generate trading profit from Bright Minds Biosciences as its price is falling. DRUG shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bright Minds Biosciences? A short squeeze for Bright Minds Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DRUG, which in turn drives the price of the stock up even further. How often is Bright Minds Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DRUG, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies IMNM Short Interest EOLS Short Interest AUTL Short Interest ERAS Short Interest ORIC Short Interest KURA Short Interest TECX Short Interest CRGX Short Interest HUMA Short Interest PHVS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DRUG) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRUG Stock Alerts